ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #2,529Hybrid

Laboratory Investigation

Acronym:labinvest
•
Abbreviation (ISO):LAB. INVEST
•
Identifier (ISSN):0023-6837(Print)/1530-0307(Online)
•
Publisher:Springer Nature
Clarivate IF (2026)
4.1↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Laboratory Investigation

WoS Q2
24684.2520183.6820194.220205.6620215.52022520235.120244.220254.12026
Annual Impact Factor Metric
Current (2026):4.1
Scopus SJR & RankScopus Q1
1.468
#2,529

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
176

176 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
143articles/year
22.73% Gold OA•93.98% Original Research

Aims & Scope

Laboratory Investigation is an international journal owned by the United States and Canadian Academy of Pathology. Laboratory Investigation offers prompt publication of high-quality original research in all biomedical disciplines relating to the understanding of human disease and the application of new methods to the diagnosis of disease. Both human and experimental studies are welcome.

Topics Covered (Recognized by AI)
Medicine95.9%Biology90.9%Internal medicine78.5%Genetics77.4%Chemistry75.3%Biochemistry67.8%Pathology64.1%Endocrinology46.1%Immunology43.5%Cell biology34.8%Gene29%Physics24.5%Organic chemistry21.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q2
Rank68/191
IndexSCIE
JCRSCIE2026

PATHOLOGY

Q1
Rank13/89
IndexSCIE
JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q1
Rank31/191
IndexSCIE
JCISCIE2026

PATHOLOGY

Q1
Rank14/89
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.1
Articles / Year1,823
Total Citations45
2025
IF4.2
Articles / Year1,982
Total Citations483
2024
IF5.1
Articles / Year136
Total Citations835
2023
IF5
Articles / Year194
Total Citations2,240
2022
IF5.502
Articles / Year122
Total Citations2,212

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,529Scopus Q1SCImago Profile
Scopus Coverage:1952-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.468

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
4.16

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,503 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,879
3-Year Documents404
Citable Documents397

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate43.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Molecular BiologyQ1
Pathology and Forensic MedicineQ1
Cell BiologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
3区MEDICINE, RESEARCH & EXPERIMENTAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Laboratory Investigation (acronym: labinvest, abbr: LAB. INVEST, ISSN: 0023-6837) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Nature in United States since 2000. The periodical holds a Journal Impact Factor (JIF) of 4.10, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.468 (Q1), an H-index of 176.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 143 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,503 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Nature
Publication Language
English
Frequency
Monthly
Founding Year
2000
Indexing & Databases
SCIEScopusPubMed
Editorial Address
NATURE PUBLISHING GROUP, 75 VARICK ST, 9TH FLR, NEW YORK, USA, NY, 10013-1917

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4622c119-b658-475f-afce-b7652c504b07
Database Updated: 2026-10-01